Oncology Research Open Access
Home Oncology Research All Issues Volume 34 Issue 7
Volume 34 Issue 7, June 2026
Review | Open Access
Emerging Approaches in Breast Cancer: From Molecular Mechanisms to Diagnosis and Therapeutic Strategies
Published: 16 June 2026
2026, 34(7): 1
Review | Open Access
Engineering the Future of ADCs in Non-Small Cell Lung Cancer
Published: 16 June 2026
2026, 34(7): 2
Review | Open Access
Prognostic Value of Spatial and Topological Features of Tumor Microenvironment in Classic Hodgkin Lymphoma
Published: 16 June 2026
2026, 34(7): 3
Review | Open Access
Clostridiaceae in Cancer Management
Published: 16 June 2026
2026, 34(7): 4
Review | Open Access
Tissue-Agnostic Targeting in Solid Tumors: A PRISMA-Compliant Meta-Analysis of Efficacy, Safety, and Resistance Determinants Across Histologies
Published: 16 June 2026
2026, 34(7): 5
Review | Open Access
Monoclonal Antibodies and Derivatives: Therapeutic Tools for Cancer
Published: 16 June 2026
2026, 34(7): 6
Review | Open Access
A New Paradigm of Bispecific Antibodies in Clinical Management of Gastrointestinal Cancers
Published: 16 June 2026
2026, 34(7): 7
Review | Open Access
Preclinical Models of Colorectal Cancer Liver Metastasis: Therapeutic Evaluation and Translational Implications
Published: 16 June 2026
2026, 34(7): 8
Review | Open Access
Emerging Nanocarrier Strategies for Optimized Drug Delivery in the Treatment of Primary Bone Cancer
Published: 16 June 2026
2026, 34(7): 9
Review | Open Access
Resveratrol in Oral Squamous Cell Carcinoma: Preclinical Evidence and Translational Opportunities
Published: 16 June 2026
2026, 34(7): 10
Review | Open Access
The Dual Role of Natural Peptides in Cancer Therapy: Anticancer and Immunomodulatory Perspectives
Published: 16 June 2026
2026, 34(7): 11
Review | Open Access
Clinical Application Progress of Artificial Intelligence in Pancreatic Cancer: From Diagnosis to Immunotherapy
Published: 16 June 2026
2026, 34(7): 12
Review | Open Access
Immunometabolic Reprogramming in Hepatocellular Carcinoma Mechanisms, Biomarkers, and Therapeutic Implications
Published: 16 June 2026
2026, 34(7): 13
Article | Open Access
Progression-Free Survival with PARP Inhibitors According to Clinical Risk in Patients with Ovarian Cancer: An Indirect Comparison Using Reconstructed Data
Published: 16 June 2026
2026, 34(7): 14
Article | Open Access
Exploring the Role of CD44 in the Progression and Invasion of Chondrosarcoma
Published: 16 June 2026
2026, 34(7): 15
Article | Open Access
Mebendazole Shows Antiproliferative and Antimigratory Effects in Paediatric Low-Grade Glioma Models
Published: 16 June 2026
2026, 34(7): 16
Article | Open Access
Autocrine Motility Factor-Derived Tetradecapeptides as Dual-Action Chemosensitizers: Bridging Cell Competition Mechanisms with Clinical MDR Reversal in Hematological Malignancies
Published: 16 June 2026
2026, 34(7): 17
Article | Open Access
BCG Induces PD-1 Upregulation on Circulating CD8+ T Cells and IL-6 and IL-8 Secretion In Vitro
Published: 16 June 2026
2026, 34(7): 20
Article | Open Access
Targeting Dynamin-Related Protein 1 and Glucose Metabolism Reverses Acquired Resistance to Sorafenib in Liver Cancer
Published: 16 June 2026
2026, 34(7): 21
Article | Open Access
EBF1 Deficiency Drives Prostate Cancer Progression by Interfering with the Transcriptional Regulation of ITPR1
Published: 16 June 2026
2026, 34(7): 22
Article | Open Access
Single-Cell Sequencing Reveals the Heterogeneity of Glioma and Identifies IGFBP2 as A Potential Therapeutic Target
Published: 16 June 2026
2026, 34(7): 23
Article | Open Access
PARK2-Mediated PGK1 Degradation Suppresses Partial Epithelial-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer
Published: 16 June 2026
2026, 34(7): 24
Article | Open Access
Germinal Center–Like Tertiary Lymphoid Structures Mark Immune Responsiveness and Enable Checkpoint Immunotherapy in Bladder Cancer
Published: 16 June 2026
2026, 34(7): 25
Article | Open Access
PRDM1 Drives a TIM3+ Macrophage Immunosuppressive Niche via LGALS9 Signaling in Prostate Cancer Progression
Published: 16 June 2026
2026, 34(7): 26
Article | Open Access
Factors Affecting the Efficacy and Safety of First-Line Anti-PD-1 Therapy in Advanced Non-Small Cell Lung Cancer
Published: 16 June 2026
2026, 34(7): 27
Article | Open Access
PARP9 Modulates Sunitinib Resistance in Clear Cell Renal Cell Carcinoma via STAT1/IRF1 Signaling Pathway
Published: 16 June 2026
2026, 34(7): 28
Article | Open Access
Prognosis and Immunotherapy Effect of Triple-Negative Breast Cancer by Lactylation-Related Genes and Experimental Validation
Published: 16 June 2026
2026, 34(7): 29
Case Report | Open Access
Dual Immune Checkpoint Blockade in Synchronous Hepatocellular and Renal Cell Carcinoma: A Real-World Case Report of Durable Dual Response
Published: 16 June 2026
2026, 34(7): 30
Case Report | Open Access
New Paradigm in Ocular Surface Squamous Neoplasia—Insights from a Case Report on the Use of Interferon in Treatment
Published: 16 June 2026
2026, 34(7): 31
Retraction | Open Access
Retraction: CXCL5 Plays a Promoting Role in Osteosarcoma Cell Migration and Invasion in Autocrine- and Paracrine-Dependent Manners
Published: 16 June 2026
2026, 34(7): 33
Retraction | Open Access
Retraction: Knockdown of Cyclin-Dependent Kinase Inhibitor 3 Inhibits Proliferation and Invasion in Human Gastric Cancer Cells
Published: 16 June 2026
2026, 34(7): 34
Retraction | Open Access
Retraction: Long Noncoding RNA Taurine-Upregulated Gene 1 Promotes Cell Proliferation and Invasion in Gastric Cancer via Negatively Modulating miRNA-145-5p
Published: 16 June 2026
2026, 34(7): 35